DE69007065D1 - Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten. - Google Patents

Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.

Info

Publication number
DE69007065D1
DE69007065D1 DE90312713T DE69007065T DE69007065D1 DE 69007065 D1 DE69007065 D1 DE 69007065D1 DE 90312713 T DE90312713 T DE 90312713T DE 69007065 T DE69007065 T DE 69007065T DE 69007065 D1 DE69007065 D1 DE 69007065D1
Authority
DE
Germany
Prior art keywords
diadenosine
tetraphosphate
medicament
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90312713T
Other languages
English (en)
Other versions
DE69007065T2 (de
Inventor
Niro Inaba
Kunihiro Okamura
Tetsuaki Yamaura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Unitika Ltd
Original Assignee
Fujirebio Inc
Unitika Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc, Unitika Ltd filed Critical Fujirebio Inc
Application granted granted Critical
Publication of DE69007065D1 publication Critical patent/DE69007065D1/de
Publication of DE69007065T2 publication Critical patent/DE69007065T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69007065T 1989-11-24 1990-11-22 Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten. Expired - Fee Related DE69007065T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1306092A JP2783880B2 (ja) 1989-11-24 1989-11-24 心臓病治療剤

Publications (2)

Publication Number Publication Date
DE69007065D1 true DE69007065D1 (de) 1994-04-07
DE69007065T2 DE69007065T2 (de) 1994-06-09

Family

ID=17952934

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69007065T Expired - Fee Related DE69007065T2 (de) 1989-11-24 1990-11-22 Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.

Country Status (4)

Country Link
US (1) US5219841A (de)
EP (1) EP0437929B1 (de)
JP (1) JP2783880B2 (de)
DE (1) DE69007065T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0812581A (ja) 1994-06-30 1996-01-16 Fujirebio Inc 虚血性心疾患治療剤
US5712258A (en) * 1995-03-23 1998-01-27 The Trustees Of The University Of Pennsylvania Inotropic ADP and ATP analogues and their pharmaceutical compositions
US7348315B2 (en) 1995-03-23 2008-03-25 The University Of Connecticut Methods of treating heart failure with modified ATP, ADP and AMP compounds
US5874420A (en) * 1995-12-26 1999-02-23 Allegheny University Of The Health Sciences Process for regulating vagal tone
WO1997024146A1 (en) * 1995-12-28 1997-07-10 The General Hospital Corporation Cardiovascular and thrombus imaging agents, methods and kits
AU8351498A (en) * 1997-07-17 1999-02-10 William Harvey Research Limited Use of adenosine tri- or tetra-phosphates and their analogues for the reatment of cerebral infarction
BR0302750A (pt) * 2003-08-08 2005-03-29 Catarinense S A Lab Uso de produto compreendendo material vegetal das espécies trichilia sp. associada ou não para a reversão/combate da fibrilação ventricular; composição farmacêutica compreendendo o referido material vegetal para a reversão/combate da fibrilação ventricular; método para a reversão/combate da fibrilação ventricular usando o referido material vegetal; uso do referido material vegetal para a produção de uma composição farmacêutica para a reversão/combate da fibrilação ventricular
WO2008063806A2 (en) * 2006-10-24 2008-05-29 Paul Zamecnik Medical device coatings and coated stents
US20100286765A1 (en) * 2009-05-07 2010-11-11 Paul Zamecnik Medical Device Coatings and Coated Stents
GB201209244D0 (en) * 2012-05-25 2012-07-04 Globalacorn Ltd Compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321462A (en) * 1963-07-15 1967-05-23 Syntex Corp Process for the preparation of nucleoside polyphosphates
JPS62278992A (ja) * 1986-05-28 1987-12-03 Unitika Ltd ジアデノシン四リン酸又はその誘導体の製造方法
WO1989004321A1 (en) * 1987-11-05 1989-05-18 The Worcester Foundation For Experimental Biology Diadenosine 5', 5'''-p1, p4-tetraphosphate and analogs thereof as antithrombotic agents

Also Published As

Publication number Publication date
EP0437929A2 (de) 1991-07-24
DE69007065T2 (de) 1994-06-09
JP2783880B2 (ja) 1998-08-06
EP0437929B1 (de) 1994-03-02
US5219841A (en) 1993-06-15
JPH03167126A (ja) 1991-07-19
EP0437929A3 (en) 1991-09-25

Similar Documents

Publication Publication Date Title
OA08581A (en) Treatment of diseases caused by retroviruses.
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
IT1238825B (it) Dispositivo per la correzione chirurgica dell'ametropia.
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
EP0328924A3 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
GR3018674T3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DE69621786T2 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE68905657T2 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
EP0416604A3 (en) Paf-antagonists for the preparation of a medicament, useful for the treatment of heart diseases, caused by diminished beta-receptor-stimulation
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE3578374D1 (de) Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
DE69610045T2 (de) Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen
DE69632117D1 (de) Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten
DE3777709D1 (de) Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis.
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
ATE56360T1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.
ATE58476T1 (de) Verwendung von doxaminol zur herstellung eines arzneimittels zur behandlung der peripheren arteriellen verschlusskrankheit.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
JPS6490158A (en) 1,2-diamino compound, manufacture and medicine for treating cardiac disease and circulatory disease

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee